This group is primarily comprised of a subset of HRD lacking trisomy 11 (HRD11-) MM, but also contains a fraction of patients that lacks hyperdiploidy and has high frequency of NFkB activating mutations, which has been classified as nHRD214,25,33–36. Here, NFKB1 is linked to Miyoshi myopathy.